Globus Medical Overview
- Year Founded
-
2003

- Status
-
Public
- Employees
-
5,300

- Stock Symbol
-
GMED

- Investments
-
13
- Share Price
-
$58.90
- (As of Friday Closing)
Globus Medical General Information
Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Contact Information
Website
www.globusmedical.comCorporate Office
- 2560 General Armistead Avenue
- Audubon, PA 19403
- United States
Corporate Office
- 2560 General Armistead Avenue
- Audubon, PA 19403
- United States
Globus Medical Stock Performance
As of 13-Jun-2025, Globus Medical’s stock price is $58.90. Its current market cap is $7.97B with 135M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$58.90 | $60.20 | $54.48 - $94.93 | $7.97B | 135M | 1.46M | $1.35 |
Globus Medical Financials Summary
As of 31-Mar-2025, Globus Medical has a trailing 12-month revenue of $2.51B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 9,715,180 | 11,102,253 | 7,397,100 | 7,010,021 |
Revenue | 2,510,810 | 2,519,355 | 1,568,476 | 1,022,843 |
EBITDA | 498,399 | 378,935 | 289,996 | 297,038 |
Net Income | 185,563 | 102,984 | 122,873 | 190,169 |
Total Assets | 4,711,148 | 5,251,750 | 5,086,083 | 2,076,126 |
Total Debt | 92,313 | 537,188 | 520,404 | 6,011 |
Globus Medical Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Globus Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Globus Medical Comparisons
Industry
Financing
Details
Globus Medical Competitors (25)
One of Globus Medical’s 25 competitors is Orthofix International, a Formerly PE-Backed company based in Lewisville, TX.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
NuVasive | Formerly VC-backed | San Diego, CA | ||||
Merit Medical Systems | Corporation | South Jordan, UT | ||||
Xtant Medical | Formerly VC-backed | Belgrade, MT | ||||
Spinal Elements | Private Equity-Backed | Carlsbad, CA |
Globus Medical Patents
Globus Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250186091-A1 | Dual locking polyaxial screw head | Pending | 17-Feb-2025 | ||
US-12324634-B2 | Flat panel registration fixture and method of using same | Active | 04-Mar-2024 | ||
US-20250191225-A1 | Augmenting 3d patient scans with cad model of implanted object | Pending | 07-Dec-2023 | ||
US-20250177013-A1 | Plate inserter instrument | Pending | 30-Nov-2023 | ||
US-20250160910-A1 | Large fragment plates and instruments | Pending | 21-Nov-2023 | A61B17/8057 |
Globus Medical Signals
Globus Medical Acquisitions (13)
Globus Medical’s most recent deal was a Merger/Acquisition with Nevro for . The deal was made on 03-Apr-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Nevro | 03-Apr-2025 | Merger/Acquisition | Therapeutic Devices | ||
NuVasive | 01-Sep-2023 | Merger/Acquisition | Surgical Devices | ||
Capstone Surgical Technologies | 04-Nov-2021 | Merger/Acquisition | Surgical Devices | ||
Synoste | 01-May-2020 | Merger/Acquisition | Therapeutic Devices | ||
StelKast | 01-Jun-2019 | Merger/Acquisition | Therapeutic Devices |
Globus Medical ESG
Risk Overview
Risk Rating
Updated April, 11, 2025
29.39 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile

Healthcare
Industry
of 564
Rank
Percentile

Medical Devices
Subindustry
of 196
Rank
Percentile

Globus Medical Affiliates
Subsidiaries (4)
Name | Industry | Location | Year Founded |
---|---|---|---|
Synoste | Espoo, Finland | 2012 | |
Surgimap | New York, NY | 2008 | |
Nevro | Redwood City, CA | 2006 | |
NuVasive | San Diego, CA | 1997 |
Globus Medical FAQs
-
When was Globus Medical founded?
Globus Medical was founded in 2003.
-
Where is Globus Medical headquartered?
Globus Medical is headquartered in Audubon, PA.
-
What is the size of Globus Medical?
Globus Medical has 5,300 total employees.
-
What industry is Globus Medical in?
Globus Medical’s primary industry is Therapeutic Devices.
-
Is Globus Medical a private or public company?
Globus Medical is a Public company.
-
What is Globus Medical’s stock symbol?
The ticker symbol for Globus Medical is GMED.
-
What is the current stock price of Globus Medical?
As of 13-Jun-2025 the stock price of Globus Medical is $58.90.
-
What is the current market cap of Globus Medical?
The current market capitalization of Globus Medical is $7.97B.
-
What is Globus Medical’s current revenue?
The trailing twelve month revenue for Globus Medical is $2.51B.
-
Who are Globus Medical’s competitors?
Orthofix International, NuVasive, Merit Medical Systems, Xtant Medical, and Spinal Elements are some of the 25 competitors of Globus Medical.
-
What is Globus Medical’s annual earnings per share (EPS)?
Globus Medical’s EPS for 12 months was $1.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »